Serum (1→3)-β-D-glucan levels in HIV-infected individuals are associated with immunosuppression, inflammation, and cardiopulmonary function

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 4, 2012, Pages 462-468

  Morris, Alison ^a   Hillenbrand, Maria ^a   Finkelman, Malcolm ^b   George, M Patricia ^a   Singh, Vikas ^a   Kessinger, Cathy ^a   Lucht, Lorrie ^a   Busch, Michelle ^a   McMahon, Deborah ^a   Weinman, Renee ^a   Steele, Chad ^c   Norris, Karen A ^a   Gingo, Matthew R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Asociates of Cape Cod   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

(1 3) D glucan; COPD; emphysema; HIV; inflammation; pulmonary hypertension

Indexed keywords

ANTIRETROVIRUS AGENT; BETA 1,3 GLUCAN; CD38 ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CARDIOPULMONARY FUNCTION; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL WALL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; FUNGAL CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFLAMMATION; LIMULUS LYSATE TEST; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SPECIES TRANSLOCATION; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE ACTIVATION; TRICUSPID VALVE REGURGITATION;

EID: 84870295630     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318271799b     Document Type: Article

References (40)

1. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371. (Pubitemid 44924494)
2. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis. 2009;199:1175-1180.
3. Ancuta P, Kamat A, Kunstman KJ, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One. 2008;3:e2516.
4. Marchetti G, Bellistri GM, Borghi E, et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS. 2008;22:2035-2038.
5. Marchetti G, Cozzi-Lepri A, Merlini E, et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS. 2011;25:1385-1394.
6. Acosta J, Catalan M, Del Palacio-Perez-Medel A, et al. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1, 3)-beta-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease. Eur J Clin Microbiol Infect Dis. 2012;31:721-731.
7. Sax PE, Komarow L, Finkelman MA, et al. Blood (1/3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. Clin Infect Dis. 2011;53:197-202.
8. Desmet S, Van Wijngaerden E, Maertens J, et al. Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematolog-ical malignancy. J Clin Microbiol. 2009;47:3871-3874.
9. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and mye-lodysplastic syndrome. Clin Infect Dis. 2004;39:199-205. (Pubitemid 38971490)
10. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1/3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41:654-659. (Pubitemid 41170353)
11. Hoffman OA, Standing JE, Limper AH. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J Immunol. 1993;150:3932-3940. (Pubitemid 23129775)
12. Brown GD, Gordon S. Immune recognition of fungal beta-glucans. Cell Microbiol. 2005;7:471-479.
13. Gingo MR, George MP, Kessinger CJ, et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med. 2010;182:790-796.
14. Crothers K, Butt AA, Gibert CL, et al. Increased COPD among HIVpositive compared to HIV-negative veterans. Chest. 2006;130:1326-1333. (Pubitemid 44786723)
15. Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183:388-395.
16. Hsue PY, Deeks SG, Farah HH, et al. Role of HIV and human herpes-virus-8 infection in pulmonary arterial hypertension. AIDS. 2008;22:825-833. (Pubitemid 351563831)
17. Mondy KE, Gottdiener J, Overton ET, et al. High prevalence of echo-cardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy. Clin Infect Dis. 2011;52:378-386.
18. Morris A, Gingo MR, George MP, et al. Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era. AIDS. 2012;26:731-740.
19. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470. (Pubitemid 29135798)
20. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720-735. (Pubitemid 41448672)
21. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirom-etry. Eur Respir J. 2005;26:319-338.
22. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179-187. (Pubitemid 29036522)
23. Neas LM, Schwartz J. The determinants of pulmonary diffusing capacity in a national sample of U.S. adults. Am J Respir Crit Care Med. 1996; 153:656-664. (Pubitemid 26051344)
24. Gershman NH, Wong HH, Liu JT, et al. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur Respir J. 1996;9:2448-2453. (Pubitemid 26407891)
25. Fahy JV, Boushey HA, Lazarus SC, et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med. 2001;163:1470-1475. (Pubitemid 32506618)
26. Morris A, Kingsley LA, Groner G, et al. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS. 2004; 18:793-798. (Pubitemid 38535008)
27. Henry WL, DeMaria A, Gramiak R, et al. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation. 1980;62:212-217. (Pubitemid 10035638)
28. Quinones MA, Otto CM, Stoddard M, et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15:167-184.
29. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70:657-662. (Pubitemid 14020664)
30. Borgeson DD, Seward JB, Miller FA Jr, et al. Frequency of Doppler measurable pulmonary artery pressures. J Am Soc Echocardiogr. 1996;9:832-837.
31. Balagopal A, Philp FH, Astemborski J, et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology. 2008;135:226-233. (Pubitemid 351899010)
32. Anselmi A, Vendrame D, Rampon O, et al. Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy. Clin Exp Immunol. 2007; 150:442-450. (Pubitemid 350098747)
33. Wallet MA, Rodriguez CA, Yin L, et al. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS. 2010;24:1281-1290.
34. Samonis G, Gikas A, Toloudis P, et al. Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur J Clin Microbiol Infect Dis. 1994;13:665-667. (Pubitemid 24286870)
35. Brown GD, Gordon S. Fungal beta-glucans and mammalian immunity. Immunity. 2003;19:311-315.
36. Lee JN, Lee DY, Ji IH, et al. Purification of soluble beta-glucan with immune-enhancing activity from the cell wall of yeast. Biosci Biotechnol Biochem. 2001;65:837-841.
37. Seibold MA, Donnelly S, Solon M, et al. Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. J Allergy Clin Immunol. 2008;122:944-950.e943.
38. Chupp GL, Lee CG, Jarjour N, et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med. 2007;357:2016-2027. (Pubitemid 350106709)
39. Letuve S, Kozhich A, Humbles A, et al. Lung chitinolytic activity and chitotriosidase are elevated in chronic obstructive pulmonary disease and contribute to lung inflammation. Am J Pathol. 2010;176:638-649.
40. Otsuka K, Matsumoto H, Niimi A, et al. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease. Respiration. 2012;83:507-519.